Lupin Limited — Updates, 11-10-2025: General Updates
11-10-2025 | 12:06 pm
11-10-2025 | 12:06 pm
Lupin's U.S. Somerset facility underwent a U.S. FDA Pre-Approval Inspection, ending with one observation. The company commits to addressing the observation swiftly and maintaining cGMP standards across all facilities.
No comments yet. Be the first to comment!
